556.0000 -4.05 (-0.72%)
NSE Dec 29, 2025 15:31 PM
Volume: 50,360
 

556.00
-0.72%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Promoters unpledged 3.63% of shares in last quarter. Total pledge stands at 35.32% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended